Naloxone Becomes Over-the-Counter, Pharmacists Prepare for Increased Demand

In a move that is expected to save lives, the Food and Drug Administration (FDA) has approved Naloxone for over-the-counter (OTC) sale (as of March 29, 2023). Naloxone is a medication that can reverse the effects of an opioid overdose. It is currently available by prescription, but the FDA's decision to make it OTC will make it much easier for people to get their hands on this life-saving drug.

Making Naloxone OTC is expected to have a significant impact on the number of lives that are saved from opioid overdoses. A study by the National Institute on Drug Abuse found that making naloxone OTC could prevent up to 115,000 opioid overdose deaths over the next decade.

The FDA's decision to make naloxone OTC is a major step forward in the fight against the opioid epidemic. However, it is important to note that naloxone is not a cure for opioid addiction. It is a rescue medication that can save lives, but it is not a substitute for treatment.

Pharmacists will play a critical role in making naloxone OTC a success. They will be responsible for dispensing the medication and providing education to patients about how to use it. Pharmacists will also be on the front lines of the fight against the opioid epidemic, and they will be able to play a major role in saving lives.

Impact on Pharmacists

The impact of naloxone becoming OTC on pharmacists is expected to be significant. Pharmacists will now be responsible for dispensing naloxone to anyone who wants it, regardless of whether they have a prescription. This will require pharmacists to be trained on how to use and administer naloxone, as well as how to provide education to patients about the medication.

In addition, pharmacists will need to be prepared to deal with the increased demand for naloxone that is expected to result from its OTC status. This could lead to longer wait times for patients who are seeking naloxone, as well as increased stress for pharmacists who are already facing a number of challenges.

Despite the challenges, the potential benefits of naloxone becoming OTC are significant. By making naloxone more accessible, the FDA is taking a major step forward in the fight against the opioid epidemic. Pharmacists will play a critical role in this effort, and they are well-positioned to make a real difference in the lives of their patients.

How Pharmacists Can Prepare

There are a number of things that pharmacists can do to prepare for the transition of naloxone to OTC status. These include:

• Training on how to use and administer naloxone

• Providing education to patients about the medication

• Preparing for increased demand

• Working with other healthcare professionals to raise awareness about naloxone

Pharmacists should know the following about dispensing and administering naloxone:

• Naloxone is a medication that can reverse the effects of an opioid overdose.

• Naloxone is available in two forms: a nasal spray and an injection.

• Naloxone can be administered by anyone, even if they have no medical training.

• Naloxone is safe and effective.

• Naloxone does not cause addiction.

When dispensing naloxone, pharmacists should:

• Counsel patients on the signs and symptoms of an opioid overdose.

• Teach patients how to use naloxone.

• Provide patients with a copy of the naloxone prescribing information.

• Encourage patients to carry naloxone with them at all times.

When administering naloxone, pharmacists should:

• Check the patient's breathing.

• If the patient is not breathing, administer naloxone as directed.

• Call 911.

LOOKING FOR NAPLEX OR MPJE PRACTICE EXAMS?

PassRXnow offers MPJE practice content for 15+ states and 600+ NAPLEX questions covering clinical, patient profile, calculations, and top 200 generics/brand name drugs. All NAPLEX and MPJE practice exams have answers, explanations, and references. 1000’s of questions, all updated frequently.  Check out our offerings to help you prepare for these critical exams

MPJE – click here

NAPLEX  - click here